The presentation will be held on November 13, 2026, at 11:30 CET via digital webcast. Kristina Torfgård, CEO, Nicholas Waters ...
The study demonstrated statistically significant efficacy advantages for zemprocitinib over placebo across the primary and ...
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor ...
(Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected ...
While Moderna preps an entry to the oncology market next year with a personalized cancer vaccine, COVID sales are holding ...
Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage biotechnology company developing potentially ...
First advancement in the second-line treatment setting for recurrent or metastatic head and neck cancer in a decade, bringing ...
Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company with the goal of being ...
The BioSpace 40 Under 40 honoree helped steer Forge’s sale to Ajinomoto. Now, Samantha Piteri-Molina sees opportunities in AI ...
Now Accepting Applications: Founders’ Bench Award for Ophthalmology Innovation University Lab Partners (ULP), in partnership ...
Sarepta Therapeutics’ newly minted CEO Michael Severino laid out his path to returning the muscular dystrophy therapy maker ...
(NASDAQ: BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results